Larimar Therapeutics, Inc. · NASDAQ:LRMR
Hamilton Thomas Edward bought 50,000 Larimar Therapeutics, Inc. shares (Form 4)
Traded Jul 6, 2026 · Filed Jul 8, 2026
On Jul 6, 2026, Hamilton Thomas Edward (Director) bought 50,000 Larimar Therapeutics, Inc. shares at US$3.34 for US$167K, leaving 714,798 shares. Filed Jul 8, 2026 (Form 4).
- Bought
- 50,000 shares
- Price
- US$3.34
- Value
- US$167K
- Holding after
- 714,798 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Buy | 50,000 | US$3.34 | 714,798 | Direct |
Source
Related
- Larimar Therapeutics, Inc.
- Hamilton Thomas Edward
- Larimar Therapeutics, Inc. shareholders
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026